Skip to main navigation Skip to search Skip to main content

Dominant negative inhibition by fragments of a monomeric enzyme

  • John Edward A. Michaels
  • , Paul Schimmel
  • , Kiyotaka Shiba
  • , W. Todd Miller
  • Stony Brook University
  • Massachusetts Institute of Technology
  • Japanese Foundation for Cancer Research

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Dominant negative inhibition is most commonly seen when a mutant subunit of a multisubunit protein is coexpressed with the wild-type protein so that assembly of a functional oligomer is impaired. By analogy, it should he possible to interfere with the functional assembly of a monomeric enzyme by interfering with the folding pathway. Experiments in vitro by others suggested that fragments of a monomeric enzyme might be exploited for this purpose. We report here dominant negative inhibition of bacterial cell growth by expression of fragments of a tRNA synthetase. Inhibition is fragment- specific, as not all fragments cause inhibition. An inhibitory fragment characterized in more detail forms a specific complex with the intact enzyme in vivo, leading to enzyme inactivation. This fragment also associated stoichiometrically with the full-length enzyme in vitro after denaturation and refolding, and the resulting complex was catalytically inactive. Inhibition therefore appears to arise from an interruption in the folding pathway of the wild-type enzyme, thus suggesting a new strategy to design dominant negative inhibitors of monomeric enzymes.

Original languageEnglish
Pages (from-to)14452-14455
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Volume93
Issue number25
DOIs
StatePublished - Dec 10 1996

Fingerprint

Dive into the research topics of 'Dominant negative inhibition by fragments of a monomeric enzyme'. Together they form a unique fingerprint.

Cite this